Amorphin--24-vicyanoside (C34H4O16(2)H2O)--in a dose of 10 mg/kg orally decreases the content of cholesterol, total lipids, atherogenic lipoproteids in the blood and organs of intact rats and rats with endogenous or ethanol hyperlipemia, inhibits the development of experimental atherosclerosis in rabbits induced by the combination of risk factors (cholesterol + glucose + hypodynamia), decreases the content of lipids in the blood and organs (especially in aorta), prevents the development of morphological manifestations of the aorta atherosclerosis.

Download full-text PDF

Source

Publication Analysis

Top Keywords

decreases content
8
blood organs
8
[hypolipidemic hypocholesterolemic
4
hypocholesterolemic antisclerotic
4
antisclerotic action
4
action rotenoid
4
rotenoid glycoside
4
glycoside amorphin]
4
amorphin] amorphin--24-vicyanoside
4
amorphin--24-vicyanoside c34h4o162h2o--in
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!